BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 31850909)

  • 41. Reprint of: lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas & renal cell carcinoma.
    Gupta S; Stanton ML; Reynolds JP; Whaley RD; Herrera-Hernandez L; Jimenez RE; Cheville JC
    Hum Pathol; 2023 Mar; 133():136-152. PubMed ID: 36894367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutated ASXL1 upregulates mTOR expression in renal cell carcinoma with fibromyomatous stroma.
    Liu Y; Zhou L; Xu H; Gu Y; Dong L; Yang X; Wang C
    Virchows Arch; 2023 Dec; ():. PubMed ID: 38102390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TSC1/2 mutations as markers of response to everolimus in metastatic renal cell carcinoma: A case study.
    Jacob LA; Shafi G
    Indian J Cancer; 2019; 56(3):274-275. PubMed ID: 31389395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney.
    Kapur P; Gao M; Zhong H; Chintalapati S; Mitui M; Barnes SD; Zhou Q; Miyata J; Carrillo D; Malladi VS; Rakheja D; Pedrosa I; Xu L; Kinch L; Brugarolas J
    Mod Pathol; 2022 Mar; 35(3):333-343. PubMed ID: 34538873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New insights in the new WHO classification of adult renal tumors.
    Hes O; Michalová K; Pivovarčíková K
    Cesk Patol; 2022; 67(4):187-191. PubMed ID: 36513503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma.
    Kwiatkowski DJ; Choueiri TK; Fay AP; Rini BI; Thorner AR; de Velasco G; Tyburczy ME; Hamieh L; Albiges L; Agarwal N; Ho TH; Song J; Pignon JC; Barrios PM; Michaelson MD; Van Allen E; Krajewski KM; Porta C; Pal S; Bellmunt J; McDermott DF; Heng DYC; Gray KP; Signoretti S
    Clin Cancer Res; 2016 May; 22(10):2445-2452. PubMed ID: 26831717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sclerosing TSC1 mutated renal cell carcinoma: An unusual pattern mimicking MITF family translocation renal cell carcinoma.
    Williamson SR; Cardili L; Whiteley LJ; Sanchez J; Kis O
    Genes Chromosomes Cancer; 2020 Oct; 59(10):591-594. PubMed ID: 32418252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
    Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clear cell papillary renal cell carcinoma, renal angiomyoadenomatous tumor, and renal cell carcinoma with leiomyomatous stroma relationship of 3 types of renal tumors: a review.
    Hes O; Compérat EM; Rioux-Leclercq N
    Ann Diagn Pathol; 2016 Apr; 21():59-64. PubMed ID: 26897641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. "Oncocytoid Renal Cell Carcinomas After Neuroblastoma" Represent TSC -mutated Eosinophilic Solid and Cystic Renal Cell Carcinomas : Association With Prior Childhood Malignancy and Multifocality With Therapeutic Implications.
    Argani P; Medeiros LJ; Matoso A; Baraban E; Lotan T; Pawel BR; McKenney JK; Mehra R; Falzarano SM; Pallavajjalla A; Lin MT; Patel S; Rawwas J; Bendel AE; Gagan J; Palsgrove DN
    Am J Surg Pathol; 2023 Dec; 47(12):1335-1348. PubMed ID: 37522346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal cell carcinoma with leiomyomatous stroma: a review of an emerging entity distinct from clear cell conventional renal cell carcinoma.
    Yeh YA; Constantinescu M; Chaudoir C; Tanner A; Serkin F; Yu X; Fazili T; Lurie AA
    Am J Clin Exp Urol; 2019; 7(5):321-326. PubMed ID: 31763363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Papillary pattern in clear cell renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 23 cases.
    Alaghehbandan R; Ulamec M; Martinek P; Pivovarcikova K; Michalova K; Skenderi F; Hora M; Michal M; Hes O
    Ann Diagn Pathol; 2019 Feb; 38():80-86. PubMed ID: 30502717
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
    Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
    [No Abstract]   [Full Text] [Related]  

  • 55. Oncocytic renal neoplasms with diffuse keratin 7 immunohistochemistry harbor frequent alterations in the mammalian target of rapamycin pathway.
    Mohanty SK; Satapathy A; Aggarwal A; Mishra SK; Sampat NY; Sharma S; Williamson SR
    Mod Pathol; 2022 Mar; 35(3):361-375. PubMed ID: 34802045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Eosinophilic solid and cystic renal cell carcinoma with TSC2 gene mutations in children].
    Yang WP; Chang KTE; Xu HY; Kuick CH; Ng EHQ; Huang H; Xiong F; Wu Y; Zeng ST; Fan JX; Loh XY
    Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):693-698. PubMed ID: 32610380
    [No Abstract]   [Full Text] [Related]  

  • 57. Atypical tuberous sclerosis complex presenting as familial renal cell carcinoma with leiomyomatous stroma.
    Bah I; Fahiminiya S; Bégin LR; Hamel N; D'Agostino MD; Tanguay S; Foulkes WD
    J Pathol Clin Res; 2018 Jul; 4(3):167-174. PubMed ID: 29659200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Papillary renal cell carcinoma with prominent spindle cell stroma - tumor mimicking mixed epithelial and stromal tumor of the kidney: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 6 cases.
    Rogala J; Kojima F; Alaghehbandan R; Agaimy A; Martinek P; Ondic O; Ulamec M; Sperga M; Michalova K; Pivovarcikova K; Pitra T; Hora M; Ferak I; Marečková J; Michal M; Hes O
    Ann Diagn Pathol; 2020 Feb; 44():151441. PubMed ID: 31862520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal disease in tuberous sclerosis complex: pathogenesis and therapy.
    Lam HC; Siroky BJ; Henske EP
    Nat Rev Nephrol; 2018 Nov; 14(11):704-716. PubMed ID: 30232410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex.
    Williamson SR; Hornick JL; Eble JN; Gupta NS; Rogers CG; True L; Grignon DJ; Cheng L
    Hum Pathol; 2018 May; 75():10-15. PubMed ID: 29180251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.